Clinical trial
The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV…
NCT00061256 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00061256 |
|---|---|
| Title | The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients |
| Official title | A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Once-Weekly Alendronate in HIV-Infected Subjects With Decreased Bone Mineral Density Receiving Calcium and Vitamin D |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Alendronate, Calcium carbonate, Vitamin D |
| Enrollment | 80 |
| Completion | Sep 1, 2006 |
| First posted | May 23, 2003 |
| Last update posted | Aug 7, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: